We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
S&P Global's (SPGI) Unit Inks Partnership Deal With Axioma
Read MoreHide Full Article
S&P Global Inc.’s (SPGI - Free Report) division, S&P Dow Jones Indices ("S&P DJI") yesterday announced that it has inked a deal to collaborate with Axioma, a provider of enterprise market risk and portfolio analytics solutions.
The collaboration will see the integration of S&P DJI's global brand recognition and capabilities in indices (serving institutions and intermediaries) with Axioma's robust analytical tool kit and expertise.
So far this year, shares of S&P Global have gained 6.3%, outperforming the 1.9% rise of the Zacks S&P 500 composite.
Creation of Optimized Factor-based Strategy Indices in Focus
The tie-up is expected to produce Axioma-powered S&P DJI branded indices. These indices will be designed to deliver optimized single- and multi-factor solutions that advance the forefront of smart beta, ESG and related investment themes.
According to Jamie Farmer, Chief Commercial Officer, S&P Dow Jones Indices, "This collaboration will accelerate the pace of innovation to deliver transparent, strategic factor indices that are designed to meet the increasing demand for benchmarks that encapsulate quantitative investment methodologies."
Bottom Line
By leveraging Axioma’s systematic portfolio-construction capabilities and risk analytics, S&P DJI will be expanding its factor index offering, which, in turn, should benefit its top line.
In the last reported quarter, S&P DJI’s revenues improved 10% year over year, courtesy of growth in asset-linked fees and revenues associated with data and custom subscriptions. The segment contributed around 13% to S&P Global’s total revenues in third-quarter 2018.
A few better-ranked stocks in the broader Business Services sector include Paychex, Inc. (PAYX - Free Report) , Genpact Ltd. (G - Free Report) and WEX Inc. (WEX - Free Report) , each carrying a Zacks Rank #2 (Buy). The long-term expected EPS (three to five years) growth rate for Paychex, Genpact and WEX is 8.5%, 10% and 15%, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
S&P Global's (SPGI) Unit Inks Partnership Deal With Axioma
S&P Global Inc.’s (SPGI - Free Report) division, S&P Dow Jones Indices ("S&P DJI") yesterday announced that it has inked a deal to collaborate with Axioma, a provider of enterprise market risk and portfolio analytics solutions.
The collaboration will see the integration of S&P DJI's global brand recognition and capabilities in indices (serving institutions and intermediaries) with Axioma's robust analytical tool kit and expertise.
So far this year, shares of S&P Global have gained 6.3%, outperforming the 1.9% rise of the Zacks S&P 500 composite.
Creation of Optimized Factor-based Strategy Indices in Focus
The tie-up is expected to produce Axioma-powered S&P DJI branded indices. These indices will be designed to deliver optimized single- and multi-factor solutions that advance the forefront of smart beta, ESG and related investment themes.
According to Jamie Farmer, Chief Commercial Officer, S&P Dow Jones Indices, "This collaboration will accelerate the pace of innovation to deliver transparent, strategic factor indices that are designed to meet the increasing demand for benchmarks that encapsulate quantitative investment methodologies."
Bottom Line
By leveraging Axioma’s systematic portfolio-construction capabilities and risk analytics, S&P DJI will be expanding its factor index offering, which, in turn, should benefit its top line.
In the last reported quarter, S&P DJI’s revenues improved 10% year over year, courtesy of growth in asset-linked fees and revenues associated with data and custom subscriptions. The segment contributed around 13% to S&P Global’s total revenues in third-quarter 2018.
Zacks Rank & Stocks to Consider
Currently, S&P Global is a Zacks Rank #3 (Hold) stock. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
A few better-ranked stocks in the broader Business Services sector include Paychex, Inc. (PAYX - Free Report) , Genpact Ltd. (G - Free Report) and WEX Inc. (WEX - Free Report) , each carrying a Zacks Rank #2 (Buy). The long-term expected EPS (three to five years) growth rate for Paychex, Genpact and WEX is 8.5%, 10% and 15%, respectively.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>